Acting FDA chief isn't interested in permanent role: Key facts
Kyle Diamantas, an attorney who previously led the FDA's food program, has been named acting commissioner of the Food and Drug Administration following the resignation of Commissioner Marty Makary. Diamantas is stepping in on an interim basis while the administration searches for a permanent replacement, who will need to be nominated by the President and confirmed by the Senate. Reports indicate that Diamantas is viewed as a steady hand to manage the agency through this transition. There is no indication that Diamantas is seeking the permanent role, suggesting that he is not interested in becoming the next permanent FDA commissioner.
Acting FDA chief isn't interested in permanent role: Key facts
Kyle Diamantas, an attorney who previously led the FDA's food program, has been named acting commissioner of the Food and Drug Administration following the resignation of Commissioner Marty Makary. Diamantas is stepping in on an interim basis while the administration searches for a permanent replacement, who will need to be nominated by the President and confirmed by the Senate. Reports indicate that Diamantas is viewed as a steady hand to manage the agency through this transition. There is no indication that Diamantas is seeking the permanent role, suggesting that he is not interested in becoming the next permanent FDA commissioner.